Genomic Health, Inc.
| Nasdaq: GHDX
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in breast and colon cancers. It is dedicated to addressing the difficult challenges of cancer treatment by utilizing genomics to help physicians and patients choose the most appropriate treatment options with optimal confidence. Genomic Health was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott and Steven Shak in August 2000 and is headquartered in Redwood City, CA.